|
|
|
| Effect of the Clinical Efficacy and Gastroscopic Histology by Jinghuaweikang Capsules Combined with Mo Luo Dan in the Treatment of Senile Gastritis with Hp Infection |
| XIE Da |
| Beijing Royal Integrative Medicine Hospital, Beijing 102209, China |
|
|
|
|
Abstract Objective: To investigate the effect of the clinical efficacy and gastroscopic histology by Jinghuaweikang capsules combined with Mo Luo Dan in the treatment of senile Gastritis with Hp infection .Method: 80 senile chronic atrophic gastritis with Hp positive patients from February 2014 to February 2016 in our hospital were selected and randomly divided into two groups. The control group of 40 cases, treated with routine clinical treatment; 40 cases in the experimental group were treated on the basis of the control group with Jinghuaweikang capsules combined with Mo Luo Dan. Observe two groups of patients before and after treatment of Hp eradication rate, gastric mucosal atrophy, intestinal metaplasia, dysplasia and other pathological score, the results using SPSS 19 statistical software for data analysis. Result: Compared with before treatment,two groups of patients Gastric mucosal atrophy, intestinal metaplasia and intraepithelial neoplasia levels were higher after treatment.Compared with the control group, the experimental group patients eradication rate of Hp was higher than that of control group, such as gastric mucosal atrophy, intestinal metaplasia and intraepithelial neoplasia lower than the control group, the differences were statistically significant (P < 0.05). Conclusion: Jinghuaweikang capsules combined with Luo Dan friction can be effective in the treatment of Hp infection, inhibition of gastric mucosal atrophy, intestinal metaplasia, intraepithelial neoplasia and other pathological changes, and has better clinical efficacy, worthy of clinical application.
|
|
|
| Fund:北京市科技计划项目,(编号:D08080203640903) |
|
|
|
[1] 杨大富.慢性胃炎的中医辨证治疗[J].现代中西医结合杂志,2005,14(5):632~633.
[2] 鲁香凤.慢性胃炎不同证型与胃黏膜病理变化相关性研究进展[J].中国中西医结合消化杂志,2016,24(5):405~410.
[3] Kobayashi S,Ogura M,Suzawa N,et al.(18)F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis[J].BMC medical imaging,2016,16(1):58.
[4] Cui J,Liu Y,Hu Y,et al.NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis[J].Journal of pharmaceutical and biomedical analysis,2017,132(15):77~86.
[5] 张声生, 牧童,姜良铎.慢性萎缩性胃炎癌前病变中医药防治研究进展[J].中国中西医结合消化杂志,2004,12(6):376~378.
[6] 中华医学会消化病学分会.中国慢性胃炎共识意见[J].胃肠病学,2013,18(1):24~39.
[7] 岳玉武.摩罗丹联合抗幽门螺杆菌药物治疗慢性萎缩性胃炎的疗效观察[J].内蒙古医学杂志,2013,45(8):988~989.
[8] 中华中医药学会.慢性胃炎诊疗指南[J].中国中医药现代远程教育,2011,09(10):123~125.
[9] 中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组.第四次全国幽门螺杆菌感染处理共识报告[J].中华内科杂志,2012,51(10):832~837.
[10] 中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见[J].中医杂志,2010,51(8):749~753.
[11] 郑筱萸.中药新药临床研究指导原则(试行)[M].第1版.北京:中国医药科技出版社,2002.124~129. |
|
|
|
2017, Vol. 23 
